Hotchkis & Wiley Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $552M | Sell |
|
|||||
|
2025
Q1 | $773M | Buy |
|
|||||
|
2024
Q4 | $655M | Buy |
|
|||||
|
2024
Q3 | $646M | Sell |
|
|||||
|
2024
Q2 | $712M | Sell |
|
|||||
|
2024
Q1 | $778M | Sell |
|
|||||
|
2023
Q4 | $761M | Sell |
|
|||||
|
2023
Q3 | $750M | Buy |
|
|||||
|
2023
Q2 | $706M | Buy |
|
|||||
|
2023
Q1 | $594M | Buy |
|
|||||
|
2022
Q4 | $410M | Sell |
|
|||||
|
2022
Q3 | $490M | Sell |
|
|||||
|
2022
Q2 | $600M | Sell |
|
|||||
|
2022
Q1 | $845M | Sell |
|
|||||
|
2021
Q4 | $972M | Sell |
|
|||||
|
2021
Q3 | $889M | Sell |
|
|||||
|
2021
Q2 | $936M | Sell |
|
|||||
|
2021
Q1 | $936M | Buy |
|
|||||
|
2020
Q4 | $741M | Buy |
|
|||||
|
2020
Q3 | $552M | Buy |
|
|||||
|
2020
Q2 | $438M | Buy |
|
|||||
|
2020
Q1 | $377M | Buy |
|
|||||
|
2019
Q4 | $382M | Buy |
|
|||||
|
2019
Q3 | $280M | Buy |
|
|||||
|
2019
Q2 | $242M | Buy |
|
|||||
|
2019
Q1 | $162M | Sell |
|
|||||
|
2018
Q4 | $153M | Sell |
|
|||||
|
2018
Q3 | $328M | Sell |
|
|||||
|
2018
Q2 | $311M | Sell |
|
|||||
|
2018
Q1 | $293M | Sell |
|
|||||
|
2017
Q4 | $330M | Sell |
|
|||||
|
2017
Q3 | $455M | Buy |
|
|||||
|
2017
Q2 | $448M | Sell |
|
|||||
|
2017
Q1 | $587M | Sell |
|
|||||
|
2016
Q4 | $523M | Sell |
|
|||||
|
2016
Q3 | $465M | Buy |
|
|||||
|
2016
Q2 | $324M | Buy |
|
|||||
|
2016
Q1 | $318M | Sell |
|
|||||
|
2015
Q4 | $332M | Buy |
|
|||||
|
2015
Q3 | $326M | Buy |
|
|||||
|
2015
Q2 | $239M | Sell |
|
|||||
|
2015
Q1 | $353M | Sell |
|
|||||
|
2014
Q4 | $340M | Buy |
|
|||||
|
2014
Q3 | $322M | Sell |
|
|||||
|
2014
Q2 | $378M | Buy |
|
|||||
|
2014
Q1 | $328M | Buy |
|
|||||
|
2013
Q4 | $279M | Sell |
|
|||||
|
2013
Q3 | $260M | Sell |
|
|||||
|
2013
Q2 | $258M | Buy |
|